[ad_1]
According to the leading dementia research organization in the UK, the use of injections to combat the development and treatment of Alzheimer's disease could be offered to patients at this point 10 years.
The Alzheimer's Association, a British institution charged with research on the treatment of disease, dementia and nonprofit research, indicates that a series of recent mutations of drugs and medications that disrupt the work of harmful genes has brought scientists to a "turning point" in their fight against the disease.
For decades, researchers have struggled to find a cure for Alzheimer's disease, which affects 46 million people around the world, depending on the target of the harmful proteins that accumulate in the body. brain.
However, the "striking" results of a recent experiment aimed at putting an end to the work of protein-regulating genes in children born with a rare spine problem, convinced scientists that they could adopt the same approach for people at higher risk of dementia.
In an interview with the British newspaper, James Beckett, head of research at the Society, said that our right to the spine would prevent the spread and development of specific forms of diseases that may be available in less than 10 years.
The treatment, which uses "molecular scissors", will not change a person's basic genetic code, but how specific genes known to play a role in dementia communicate.
Such a drug would mainly affect about 18,000 Britons among those most at risk of developing Alzheimer's disease, accounting for nearly 2% of the total number of Britons suffering from degenerative diseases. Brain.
These include people with the first stage of Alzheimer's disease, which can affect individuals in their early thirties. There is currently no treatment for any form of the disease.
"2019 will mark a turning point in the treatment of Alzheimer's disease through genes that cause dementia," Beckett said.
"We have as much genetic knowledge as cancer researchers 30 years ago and we are investing in understanding and exploiting it," he said.
Scientists now know 25 species of genes that significantly increase the risk of contracting Alzheimer's disease, compared to a single discovery in 2012.
Researchers increasingly believe that the expression of these genes can be manipulated by CRISPR, a gene modification technique that exploits a process used by the immune system to cut DNA from invasive bacteria or so-called predatory bacteria.
The technique was widely popularized last November after Chinese scientist He Jian Kui claimed to use it to help produce the world's first genetically modified children.
Such a development would be illegal in the United Kingdom and condemned by the scientific community.
In contrast, the proposed treatment for Alzheimer's disease will take the form of a "messenger therapy", targeting how genes regulate the activity of harmful proteins, such as proteins (tau ) and (apo), in the brain.
Children with spinal muscular dystrophy, who have received this type of treatment, are still able to walk and do not depend on fans, years after waiting for their suffering.
Source link
